Fig. 1

Expression of RBM47. (A) RNA-seq of the GSE4290 dataset showed that RBM47 expression was higher in tumors than in normal tissues and positively correlated with glioma grade. (B) Immunohistochemical validation confirmed that the protein expression of RBM47 is consistent with RNA-seq data. Sample sizes in the dataset: Normal n = 23, WHO II n = 45, WHO III n = 31, WHO IV n = 81. The differences between groups were analyzed using the Wilcoxon rank-sum test. P < 0.05 was considered significantly different.